NYSE:CLB - Core Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$110.07 +0.21 (+0.19 %)
(As of 08/19/2018 02:07 AM ET)
Previous Close$110.07
Today's Range$109.1250 - $110.53
52-Week Range$86.55 - $130.34
Volume174,717 shs
Average Volume429,264 shs
Market Capitalization$4.99 billion
P/E Ratio55.04
Dividend Yield2.01%
Core Laboratories logoCore Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Oil & gas field services, not elsewhere classified


Debt-to-Equity Ratio1.53
Current Ratio2.24
Quick Ratio1.85


Trailing P/E Ratio55.04
Forward P/E Ratio45.30
P/E GrowthN/A

Sales & Book Value

Annual Sales$659.81 million
Price / Sales7.38
Cash Flow$2.5022 per share
Price / Cash43.99
Book Value$3.37 per share
Price / Book32.66


EPS (Most Recent Fiscal Year)$2.00
Net Income$83.12 million
Net Margins13.32%
Return on Equity64.13%
Return on Assets16.55%


Outstanding Shares44,210,000
Market Cap$4.99 billion

Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 13th. Investors of record on Monday, July 23rd will be given a dividend of $0.55 per share on Monday, August 13th. This represents a $2.20 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Friday, July 20th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its quarterly earnings data on Wednesday, July, 25th. The oil and gas company reported $0.59 earnings per share for the quarter, hitting analysts' consensus estimates of $0.59. The oil and gas company earned $175.48 million during the quarter, compared to analysts' expectations of $174.47 million. Core Laboratories had a net margin of 13.32% and a return on equity of 64.13%. The business's revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.51 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Monday, October, 22nd 2018. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its third quarter earnings guidance on Wednesday, July, 25th. The company provided earnings per share (EPS) guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.65. The company issued revenue guidance of $177-179 million, compared to the consensus revenue estimate of $178.49 million.

What price target have analysts set for CLB?

11 analysts have issued 1-year price targets for Core Laboratories' stock. Their forecasts range from $96.00 to $136.00. On average, they expect Core Laboratories' share price to reach $112.6940 in the next twelve months. This suggests a possible upside of 2.4% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Who are some of Core Laboratories' key competitors?

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 63)
  • Mr. Monty L. Davis, Chief Operating Officer and Sr. VP (Age 64)
  • Mr. Richard L. Bergmark, Exec. VP (Age 65)
  • Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 58)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 48)

Has Core Laboratories been receiving favorable news coverage?

Media coverage about CLB stock has been trending positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Core Laboratories earned a coverage optimism score of 0.42 on Accern's scale. They also gave media coverage about the oil and gas company an impact score of 47.67 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Core Laboratories.

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.21%), Earnest Partners LLC (4.42%), Massachusetts Financial Services Co. MA (3.95%), Epoch Investment Partners Inc. (2.59%), DF Dent & Co. Inc. (1.83%) and Sei Investments Co. (1.41%). Company insiders that own Core Laboratories stock include Kevin Daniels, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

Which institutional investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Van ECK Associates Corp, Wells Fargo & Company MN, Summit Trail Advisors LLC, Epoch Investment Partners Inc., Bank of America Corp DE, Great West Life Assurance Co. Can and Waddell & Reed Financial Inc.. View Insider Buying and Selling for Core Laboratories.

Which institutional investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, BlackRock Inc., Segall Bryant & Hamill LLC, Renaissance Technologies LLC, Grandeur Peak Global Advisors LLC, Manning & Napier Group LLC, Dimensional Fund Advisors LP and Bank of Montreal Can. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $110.07.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $4.99 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]

MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  337 (Vote Outperform)
Underperform Votes:  469 (Vote Underperform)
Total Votes:  806
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2018 by MarketBeat.com Staff

Featured Article: Trading Strategy

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.